{
  "pmcid": "7919338",
  "sha256": "a1e1eef2650b07e489d3a45875785fd665c67ff7f577d1750433425b013684e9",
  "timestamp_utc": "2025-11-10T00:07:51.679743+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.747649122807019,
    "reading_ease": 30.741210526315797,
    "word_count": 228
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "randomized into two groups"
      },
      "Participants": {
        "score": 2,
        "evidence": "patients with recurrent GBM, randomized into two groups"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Group A, with unresectable disease, received RO4929097 in a standard phase II design. Group B, with resectable disease, received the drug pre- and post-surgical resection."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the 6-month progression-free survival rate (PFS 6)"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomization was executed using [randomization method], with allocation concealment by [method]."
      },
      "Blinding": {
        "score": 0,
        "evidence": "No blinding was applied to outcome assessors, patients, or clinicians."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 47 patients were randomized, with 40 in Group A and 7 in Group B."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "The analysis was conducted using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The PFS 6 was 4% (95% CI [confidence interval])"
      },
      "Harms": {
        "score": 0,
        "evidence": "Adverse events occurred in [number] patients, with [frequency and severity] reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "The trial was registered under [trial registration number]"
      },
      "Funding": {
        "score": 0,
        "evidence": "funded by [source of funding]"
      }
    },
    "total_score": 15,
    "max_score": 25
  }
}